Can-Fite BioPharma (CANF) Operating Margin Growth (3y) (2018 - 2023)
Powered by 
Analysis
Can-Fite BioPharma (CANF) Operating Margin Growth (3y) (2018 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn | 842.00 |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn | 214.00 |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn | -963.00 |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn | 2,139.00 |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn | -1,031.00 |
| 10 | Can-Fite BioPharma | 1.80 Mn | -1.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 118,544.00 |
| Sep 30, 2023 | 22,335.00 |
| Jun 30, 2023 | 96,774.00 |
| Dec 31, 2022 | 149,233.00 |
| Sep 30, 2022 | -101,900.00 |
| Jun 30, 2022 | 60,894.00 |
| Mar 31, 2022 | -172,834.00 |
| Dec 31, 2021 | -110,842.00 |
| Sep 30, 2021 | -142,290.00 |
| Jun 30, 2021 | 65,161.00 |
| Mar 31, 2021 | -171,816.00 |
| Dec 31, 2020 | 1.19 Mn |
| Sep 30, 2020 | -139,319.00 |
| Jun 30, 2020 | -1.01 Mn |
| Dec 31, 2019 | -24.77 Mn |
| Sep 30, 2019 | -400,227.00 |
| Jun 30, 2019 | -556,069.00 |
| Mar 31, 2019 | -232,951.00 |
| Dec 31, 2018 | -1.10 Mn |
| Sep 30, 2018 | -201,035.00 |